Abstract
FR900452, a natural product isolated from the culture broth ofStreptomyces phaeofaciens No. 7739, was found to inhibit PAF-induced rabbit platelet aggregation with an IC50 of 3.7×10−7M. FR900452, 1-methyl-3-[1-[5-methylthiomethyl-6-oxo-3-(2-oxo-3-cyclopenten-1-ylidene)-2-piperazinyl]ethyl]-2-indoline, has an oxocylopentylidene group incorporated as a vinylogous amide in a diketopiperazine skeleton. This unique structure led us to synthesize diketopiperazine derivatives, 3-arylalkyl-6-substituted-piperazine-2,5-diones. their observed PAF inhibitory activity suggest that the D-D configuration of diketopiperazine is an important factor for anti-PAF activity and that the hydrophobic aromatic portion may play a specific role in the binding of the diketopiperazine to the PAF receptor.
Similar content being viewed by others
Abbreviations
- IC50 :
-
concentration required to inhibit the platelet aggregation response by 50%
- PAF:
-
platelet-activating factor, 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine
- PRP:
-
platelet-rich plasma
References
Handley, D.A. (1988)Trends Pharmacol. Sci. 13, 137–152.
Braquet, P., Touqui, L., Shen, T.Y., and Vargafting, B.B. (1987)Pharmacol. Rev. 39, 97–145.
Braquet, P., and Godfroid, J.J. (1986)Trends Pharmacol. Sci. 8, 397–403.
Okamoto, M., Yoshida, K., Uchida, I., Nishikawa, M., Kohsaka, M., and Aoki, H. (1986)Chem. Pharm. Bull. 34, 340–344.
Okamoto, M., Yoshida, K., Uchida, I., Kohsaka, M., and Aoki, H. (1986)Chem. Pharm. Bull. 34, 345–348.
Shimazaki, N., Shima, I., Hemmi, K., Tsurumi, Y., and Hashimoto, M. (1987)Chem. Pharm. Bull. 35, 3527–3530.
Okamoto, M., Yoshida, K., Nishikawa, M., Ando, T., Iwami, M., Kohsaka, M., and Aoki, H. (1986)Chem. Pharm. Bull. 34, 3005–3010.
Takase, S., Shigematsu, N., Shima, I., Uchida, I., Hashimoto, M., Toda, T., Koda, S., and Morimoto, Y. (1987)J. Org. Chem. 52, 3485–3487.
Shimazaki, N., Hemmi, K., Nakaguchi, O., Miyazaki, Y., and Hashimoto, M., European Patent No. EP 243122 (1987).
Shimazaki, N., Shima, I., Hemmi, K., and Hashimoto, M. (1987)J. Med. Chem. 30, 1706–1709.
Shima, I., Shimazaki, N., Imai, K., Hemmi, K., and Hashimoto, M. (1990)Chem. Pharm. Bull. 38, 564–566.
Author information
Authors and Affiliations
About this article
Cite this article
Shimazaki, N., Shima, I., Okamoto, M. et al. PAF inhibitory activity of diketopiperazines: Structure-activity relationships. Lipids 26, 1175–1178 (1991). https://doi.org/10.1007/BF02536526
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02536526